[Comparison of a 6-month chemotherapy and a l2-month chemotherapy in the treatment of pulmonary tuberculosis in Algerian Sahara. Cooperative study by an Algerian work team and the British Medical Research Council].
D000995:Antitubercular Agents / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage; D011718:Pyrazinamide / Q000008:administration & dosage; D012293:Rifampin / Q000008:administration & dosage; D013307:Streptomycin / Q000008:administration & dosage; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D004338:Drug Combinations; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Comparaison d'une chimiothérapie de 6 mois et d'une chimiothérapie de 12 mois dans le traitement de la tuberculose pulmonaire au Sahara algérien. Enquête coopérative d'un groupe de travail algérien et du British Medical Research Council.